Top compounds associated with response to NECAB2


Feature Type Standardized
Nominal ANOVA
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.066 0.02
mRNA apicidin CTRPv2 pan-cancer AAC 0.069 0.03
mRNA Bortezomib GDSC1000 pan-cancer AAC -0.11 0.03
mRNA BI-2536 CTRPv2 pan-cancer AAC 0.069 0.03
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.078 0.03
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.03
mRNA Curcumin CTRPv2 pan-cancer AAC -0.073 0.03
mRNA 1S,3R-RSL-3 CTRPv2 pan-cancer AAC -0.07 0.03
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC -0.076 0.03
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC -0.065 0.04
Download CSV